• Event Times (GMT+10)
  • Local Times (GMT+2)
Posters
Poster Area
Tuesday, June 17, 01:55 PM – 02:25 PM
Poster Session 5: Depression
M6A-mediated epitranscriptomic modifications in depression
Differential effects of Psilocybin and Lisuride on Serotonin and Dopamine neuronal activity and behavior
L655,708 a negative allosteric modulator at of GABAA receptor increased dopamine neuronal activity up to 1 week after a single injection
The inhibitory effect of ifenprodil on nicotine-induced addictive behaviors
Increase of the AMPA-evoked response in prefrontal cortex pyramidal neurons following acute administration of ketamine and S-ketamine in rats
5-HT2B receptors modulate the antidepressant-like response of the psychedelic LSD in rat but not in mice
Using the live rat stress paradigm to investigate approach-avoidance behaviour relevant to psychiatric disorders
Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression
Knockdown of connexin43 in astrocytes is involved in the therapeutic effect of tricyclic antidepressant amitriptyline
Discovering markers of intron retention in depression and its response to ketamine
Translational pharmacokinetic-pharmacodynamic modeling of preclinical and clinical data of the triple reuptake inhibitor JS1-1-01 to determine the recommended phase II dose
Common and distinct effects of 10-hz rTMS and iTBS on striatum-based functional connectivity in major depressive disorder: a sham-controlled study
Anxiety behavior and immune response of microglia in rats subjected to stress through the sympathetic nervous system
A multicenter clinical trial of Shuganjieyu capsules combined with Fluoxetine in the treatment of depression
Development of metabolomic biomarker signatures and diagnostic models for major depressive disorder using multiple supervised learning methods
Exploring the subjective experience of patients with treatment-resistant depression on the effects of Esketamine Nasal Spray
Effects of low-dose naltrexone on salience network connectivity in major depressive disorder
Does Excitatory/Inhibitory Balance Predict Ketamine Response in Treatment-Resistant Depression?: A Double-Blind Randomized Controlled Trial with 1H-MRS
Age-specific variations in antidepressant efficacy of transcranial magnetic stimulation for treatment-resistant depression: a real-world retrospective study
Longitudinal follow-up study of mood symptom rating, suicidality, psychological and physical health and quality of life post-rTMS in the refractory depressed patients in Taiwan
The N-3 polyunsaturated fatty acids supplementation to prevent depression recurrence in patients with late-life depression: a 52-Week double-blind, placebo-controlled trial
Predicting rTMS treatment response in depression: use of machine learning models to identify the roles of metabolic and clinical factors
Screening and diagnosis of depression: Correlation of genomic alterations with functional magnetic resonance imaging
Optimizing rTMS for depressive disorders: comparative efficacy and insights into clinical factors
Mapping peripheral molecular mechanisms associated with long-lasting effects of early life stress: a transcriptomic set-based approach
Clinical experiences with esketamine treatment at the department of psychiatry and psychological medicine, University Hospital Centre Zagreb, during the period from 2022 to 2024
Association between endocrine disruptors and depressive symptoms among Taiwanese adolescents
Toward effective speech-based depression recognition: investigating data balance and depressive symptom severity in AI approaches
Renin-angiontensin system in patients with major depressive disorder
Exploring LSD Microdosing in an open-label pilot for Major Depressive Disorder: The Interplay of Behavioral Activation, Mood Improvement, and Connectedness
Beyond the hype: examining the therapeutic potential of psychedelic microdosing through the lens of experimental control and evidence
Neural and behavioral evidence from reinforcement learning converge in support of relaxed beliefs under LSD
Altered cerebral TSPO availability and functional connectivity in patients with major depressive disorder: a preliminary multimodal imaging study combining C-11 PK11195 PET and rs-fMRI
Resting-state functional connectivity associations with suicidal ideation severity in treatment-resistant depression
Antidepressant use and antibiotics treatment failure
Optimizing sham control in transcutaneous auricular vagus nerve stimulation for chronic insomnia: a pooled analysis from two randomized clinical studies